Literature DB >> 8741020

Computer simulation of the binding of amonafide and azonafide to DNA.

S Bear1, W A Remers.   

Abstract

Intercalative binding of the antitumor drugs amonafide and azonafide to the oligonucleotide duplex d(GGCCGGCCGG).d(CCGGCCGGCC) was compared using molecular dynamics in vacuum with the AMBER force field. A number of reasonable possible binding conformations were obtained, with the azonafide complexes favored over the amonafide complexes in net binding enthalpy. In comparison with amonafide, the larger chromophore of azonafide permits greater DNA distortion and wider side-chain swings, without falling out of the intercalation site. The best model obtained was used for further dynamics on amonafide and azonafide with solvent and counterions present, and again the azonafide complex had a more favorable enthalpy. Furthermore, the enthalpy change on going from solvent into the intercalation site was less unfavorable for azonafide. These results are consistent with the stronger DNA binding of azonafide compared to amonafide, as observed in relative melting transition temperature increases and tumor inhibition in cell cultures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741020     DOI: 10.1007/bf00402824

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  13 in total

1.  In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.

Authors:  B S Andersson; M Beran; M Bakic; L E Silberman; R A Newman; L A Zwelling
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

2.  Prediction of DNA structure from sequence: a build-up technique.

Authors:  B E Hingerty; S Figueroa; T L Hayden; S Broyde
Journal:  Biopolymers       Date:  1989-07       Impact factor: 2.505

Review 3.  The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides.

Authors:  G S Manning
Journal:  Q Rev Biophys       Date:  1978-05       Impact factor: 5.318

4.  Intercalative binding to DNA of antitumour drugs derived from 3-nitro-1,8-naphthalic acid.

Authors:  M J Waring; A González; A Jiménez; D Vázquez
Journal:  Nucleic Acids Res       Date:  1979-09-11       Impact factor: 16.971

5.  Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.

Authors:  J Feigon; W A Denny; W Leupin; D R Kearns
Journal:  J Med Chem       Date:  1984-04       Impact factor: 7.446

6.  Theoretical studies of nucleic acid interactions. I. Estimates of conformational mobility in intercalated chains.

Authors:  E R Taylor; W K Olson
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

7.  Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.

Authors:  S M Sami; R T Dorr; A M Sólyom; D S Alberts; W A Remers
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

8.  2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agent.

Authors:  S M Sami; R T Dorr; D S Alberts; W A Remers
Journal:  J Med Chem       Date:  1993-03-19       Impact factor: 7.446

9.  Phase I study of mitonafide in solid tumors.

Authors:  M Llombart; A Poveda; E Forner; C Fernández-Martos; C Gaspar; M Muñoz; T Olmos; A Ruiz; V Soriano; A Benavides
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

10.  Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid.

Authors:  M F Braña; J M Castellano; C M Roldán; A Santos; D Vázquez; A Jiménez
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.